These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 21794043)

  • 1. Safety of pre-engraftment prophylactic foscarnet administration after allogeneic stem cell transplantation.
    Ishiyama K; Katagiri T; Ohata K; Hosokawa K; Kondo Y; Yamazaki H; Takami A; Nakao S
    Transpl Infect Dis; 2012 Feb; 14(1):33-9. PubMed ID: 21794043
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preemptive therapy of human herpesvirus-6 encephalitis with foscarnet sodium for high-risk patients after hematopoietic SCT.
    Ishiyama K; Katagiri T; Hoshino T; Yoshida T; Yamaguchi M; Nakao S
    Bone Marrow Transplant; 2011 Jun; 46(6):863-9. PubMed ID: 20838386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Foscarnet against human herpesvirus (HHV)-6 reactivation after allo-SCT: breakthrough HHV-6 encephalitis following antiviral prophylaxis.
    Ogata M; Satou T; Inoue Y; Takano K; Ikebe T; Ando T; Ikewaki J; Kohno K; Nishida A; Saburi M; Miyazaki Y; Ohtsuka E; Saburi Y; Fukuda T; Kadota J
    Bone Marrow Transplant; 2013 Feb; 48(2):257-64. PubMed ID: 22750998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma HHV-6 viral load-guided preemptive therapy against HHV-6 encephalopathy after allogeneic stem cell transplantation: a prospective evaluation.
    Ogata M; Satou T; Kawano R; Goto K; Ikewaki J; Kohno K; Ando T; Miyazaki Y; Ohtsuka E; Saburi Y; Saikawa T; Kadota JI
    Bone Marrow Transplant; 2008 Feb; 41(3):279-85. PubMed ID: 18037945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human herpesvirus 6 (HHV-6) reactivation and HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: a multicenter, prospective study.
    Ogata M; Satou T; Kadota J; Saito N; Yoshida T; Okumura H; Ueki T; Nagafuji K; Kako S; Uoshima N; Tsudo M; Itamura H; Fukuda T
    Clin Infect Dis; 2013 Sep; 57(5):671-81. PubMed ID: 23723198
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for developing human herpesvirus 6 (HHV-6) reactivation after allogeneic hematopoietic stem cell transplantation and its association with central nervous system disorders.
    Yamane A; Mori T; Suzuki S; Mihara A; Yamazaki R; Aisa Y; Nakazato T; Shimizu T; Ikeda Y; Okamoto S
    Biol Blood Marrow Transplant; 2007 Jan; 13(1):100-6. PubMed ID: 17222758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Human Herpesvirus-6 Encephalitis in Allogeneic Hematopoietic Stem Cell Transplantation].
    Ogata M
    Brain Nerve; 2015 Jul; 67(7):919-30. PubMed ID: 26160819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ganciclovir is effective for prophylaxis and treatment of human herpesvirus-6 in allogeneic stem cell transplantation.
    Tokimasa S; Hara J; Osugi Y; Ohta H; Matsuda Y; Fujisaki H; Sawada A; Kim JY; Sashihara J; Amou K; Miyagawa H; Tanaka-Taya K; Yamanishi K; Okada S
    Bone Marrow Transplant; 2002 Apr; 29(7):595-8. PubMed ID: 11979309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human herpesvirus 6 encephalitis in patients administered mycophenolate mofetil as prophylaxis for graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Inui Y; Yakushijin K; Okamura A; Tanaka Y; Shinzato I; Nomura T; Ichikawa H; Mizutani Y; Kitao A; Kurata K; Kakiuchi S; Miyata Y; Sanada Y; Kitagawa K; Uryu K; Kawamoto S; Yamamoto K; Matsuoka H; Murayama T; Ito M; Minami H
    Transpl Infect Dis; 2019 Feb; 21(1):e13024. PubMed ID: 30414316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human herpesvirus 6 DNA in plasma after allogeneic stem cell transplantation: incidence and clinical significance.
    Ogata M; Kikuchi H; Satou T; Kawano R; Ikewaki J; Kohno K; Kashima K; Ohtsuka E; Kadota J
    J Infect Dis; 2006 Jan; 193(1):68-79. PubMed ID: 16323134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human herpesvirus 6-related pure red cell aplasia, secondary graft failure, and clinical severe immune suppression after allogeneic hematopoietic cell transplantation successfully treated with foscarnet.
    Lagadinou ED; Marangos M; Liga M; Panos G; Tzouvara E; Dimitroulia E; Tiniakou M; Tsakris A; Zoumbos N; Spyridonidis A
    Transpl Infect Dis; 2010 Oct; 12(5):437-40. PubMed ID: 20561301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Salt-wasting nephropathy induced by foscarnet treatment for HHV-6 encephalitis in a hematopoietic stem cell transplant].
    Najima Y; Ohashi K; Ando M; Koshida A; Yamashita T; Akiyama H; Sakamaki H
    Rinsho Ketsueki; 2008 Jan; 49(1):40-5. PubMed ID: 18277595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of human herpesvirus 6B reactivation on early complications following allogeneic hematopoietic stem cell transplantation.
    Wang LR; Dong LJ; Zhang MJ; Lu DP
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1031-7. PubMed ID: 17067909
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of Prophylactic Foscarnet on Human Herpesvirus-6 Reactivation and Encephalitis in Cord Blood Transplant Recipients: A Prospective Multicenter Trial with an Historical Control Group.
    Ogata M; Takano K; Moriuchi Y; Kondo T; Ueki T; Nakano N; Mori T; Uoshima N; Nagafuji K; Yamasaki S; Shibasaki Y; Sakai R; Kato K; Choi I; Jo Y; Eto T; Kako S; Oshima K; Fukuda T
    Biol Blood Marrow Transplant; 2018 Jun; 24(6):1264-1273. PubMed ID: 29454651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors and clinical consequences of human herpesvirus 7 infection in paediatric haematopoietic stem cell transplant recipients.
    Chan PK; Li CK; Chik KW; Lee V; Shing MM; Ng KC; Cheung JL; Fok TF; Cheng AF
    J Med Virol; 2004 Apr; 72(4):668-74. PubMed ID: 14981771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transmission of integrated human herpesvirus-6 in allogeneic hematopoietic stem cell transplantation.
    Kamble RT; Clark DA; Leong HN; Heslop HE; Brenner MK; Carrum G
    Bone Marrow Transplant; 2007 Sep; 40(6):563-6. PubMed ID: 17637686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors of human herpesvirus 6 encephalitis/myelitis after allogeneic hematopoietic stem cell transplantation.
    Miyashita N; Endo T; Onozawa M; Hashimoto D; Kondo T; Fujimoto K; Kahata K; Sugita J; Goto H; Matsukawa T; Hashino S; Teshima T
    Transpl Infect Dis; 2017 Jun; 19(3):. PubMed ID: 28207973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High levels of human herpesvirus 6 DNA in peripheral blood leucocytes are correlated to platelet engraftment and disease in allogeneic stem cell transplant patients.
    Ljungman P; Wang FZ; Clark DA; Emery VC; Remberger M; Ringdén O; Linde A
    Br J Haematol; 2000 Dec; 111(3):774-81. PubMed ID: 11122137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcome of human herpesvirus-6 encephalitis after allogeneic stem cell transplantation.
    Sakai R; Kanamori H; Motohashi K; Yamamoto W; Matsuura S; Fujita A; Ohshima R; Kuwabara H; Tanaka M; Fujita H; Maruta A; Ishigatsubo Y; Fujisawa S
    Biol Blood Marrow Transplant; 2011 Sep; 17(9):1389-94. PubMed ID: 21296175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human herpesvirus 6 infection after allogeneic stem cell transplantation: incidence, outcome, and factors associated with HHV-6 reactivation.
    Jeulin H; Agrinier N; Guery M; Salmon A; Clément L; Bordigoni P; Venard V
    Transplantation; 2013 May; 95(10):1292-8. PubMed ID: 23514960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.